Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	586.4	618.7	929.03	477.01	1,711	1,541
Short-Term Investments	-	-	-	-	24.42	581.87
Cash & Short-Term Investments	586.4	618.7	929.03	477.01	1,735	2,123
Cash Growth	-46.09%	-33.40%	94.76%	-72.51%	-18.27%	6.57%
Accounts Receivable	27.51	29.32	26.96	22.41	36.6	68.31
Other Current Assets	811.91	880.08	846.16	774.78	783.14	686.98
Total Current Assets	1,426	1,528	1,802	1,274	2,555	2,878
Other Intangible Assets	-	-	-	-	-	5.67
Goodwill	924.63	924.63	-	-	-	-
Long-Term Investments	845.77	880.28	1,260	1,012	735.82	909.59
Other Long-Term Assets	16,619	16,288	15,161	14,095	13,523	13,722
Total Assets	19,815	19,621	18,223	16,382	16,814	17,516
Accounts Payable	25.48	19.4	13.37	15.17	7.91	5.62
Current Portion of Long-Term Debt	380	380	997.77	-	997.51	-
Other Current Liabilities	130.2	236.81	242.47	146.21	161.37	165.63
Total Current Liabilities	535.68	636.21	1,254	161.38	1,167	171.25
Long-Term Debt	8,576	8,571	6,615	6,135	6,119	7,096
Other Long-Term Liabilities	766.46	698.71	12.08	0.9	2.5	-
Total Long-Term Liabilities	9,343	9,270	6,627	6,136	6,121	7,096
Total Liabilities	9,879	9,906	7,880	6,298	7,288	7,267
Common Stock	0.05	0.04	0.05	0.05	0.04	0.04
Treasury Stock	-2.71	-2.61	-2.66	-2.63	-2.81	16.49
Additional Paid-in Capital	4,384	4,123	4,103	4,011	3,666	3,508
Accumulated Other Comprehensive Income	-	-	-	-	-	-2.72
Retained Earnings	2,507	2,356	2,846	2,518	1,965	2,255
Total Common Shareholders' Equity	6,888	6,477	6,947	6,526	5,628	5,777
Minority Interest	3,048	3,238	3,396	3,558	3,897	4,472
Shareholders' Equity	9,937	9,715	10,342	10,084	9,525	10,249
Total Liabilities & Equity	19,815	19,621	18,223	16,382	16,814	17,516
Total Debt	8,956	8,951	7,612	6,135	7,116	7,096
Net Cash (Debt)	-8,370	-8,332	-6,683	-5,658	-5,381	-4,973
Net Cash Per Share	-15.92	-14.76	-11.25	-9.38	-12.29	-11.99
Book Value	6,888	6,477	6,947	6,526	5,628	5,777
Book Value Per Share	13.10	11.47	11.69	10.83	12.85	13.93
Tangible Book Value	5,964	5,552	6,947	6,526	5,628	5,771
Tangible Book Value Per Share	11.34	9.84	11.69	10.83	12.85	13.91

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q